Can Fite Stock Forecast - Simple Moving Average

CANF Stock  USD 2.10  0.05  2.44%   
The Simple Moving Average forecasted value of Can Fite Biopharma on the next trading day is expected to be 2.10 with a mean absolute deviation of 0.08 and the sum of the absolute errors of 4.58. Can Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Can Fite's historical fundamentals, such as revenue growth or operating cash flow patterns.
  
At this time, Can Fite's Fixed Asset Turnover is most likely to increase in the upcoming years. The Can Fite's current Asset Turnover is estimated to increase to 0.1, while Receivables Turnover is projected to decrease to 12.42. . The Can Fite's current Common Stock Shares Outstanding is estimated to increase to about 1.3 B, while Net Loss is projected to decrease to (12.3 M).
A two period moving average forecast for Can Fite is based on an daily price series in which the stock price on a given day is replaced by the mean of that price and the preceding price. This model is best suited to price patterns experiencing average volatility.

Can Fite Simple Moving Average Price Forecast For the 29th of November

Given 90 days horizon, the Simple Moving Average forecasted value of Can Fite Biopharma on the next trading day is expected to be 2.10 with a mean absolute deviation of 0.08, mean absolute percentage error of 0.01, and the sum of the absolute errors of 4.58.
Please note that although there have been many attempts to predict Can Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Can Fite's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Can Fite Stock Forecast Pattern

Backtest Can FiteCan Fite Price PredictionBuy or Sell Advice 

Can Fite Forecasted Value

In the context of forecasting Can Fite's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Can Fite's downside and upside margins for the forecasting period are 0.02 and 6.18, respectively. We have considered Can Fite's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
2.10
2.10
Expected Value
6.18
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Can Fite stock data series using in forecasting. Note that when a statistical model is used to represent Can Fite stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria111.77
BiasArithmetic mean of the errors 0.0058
MADMean absolute deviation0.0763
MAPEMean absolute percentage error0.0331
SAESum of the absolute errors4.58
The simple moving average model is conceptually a linear regression of the current value of Can Fite Biopharma price series against current and previous (unobserved) value of Can Fite. In time series analysis, the simple moving-average model is a very common approach for modeling univariate price series models including forecasting prices into the future

Predictive Modules for Can Fite

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Can Fite Biopharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.112.106.18
Details
Intrinsic
Valuation
LowRealHigh
1.815.899.97
Details
3 Analysts
Consensus
LowTargetHigh
15.7717.3319.24
Details

Other Forecasting Options for Can Fite

For every potential investor in Can, whether a beginner or expert, Can Fite's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Can Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Can. Basic forecasting techniques help filter out the noise by identifying Can Fite's price trends.

View Can Fite Related Equities

 Risk & Return  Correlation

Can Fite Biopharma Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Can Fite's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Can Fite's current price.

Can Fite Market Strength Events

Market strength indicators help investors to evaluate how Can Fite stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Can Fite shares will generate the highest return on investment. By undertsting and applying Can Fite stock market strength indicators, traders can identify Can Fite Biopharma entry and exit signals to maximize returns.

Can Fite Risk Indicators

The analysis of Can Fite's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Can Fite's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting can stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

When determining whether Can Fite Biopharma is a strong investment it is important to analyze Can Fite's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Can Fite's future performance. For an informed investment choice regarding Can Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Can Fite to cross-verify your projections.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Can Fite. If investors know Can will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Can Fite listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.60)
Quarterly Revenue Growth
(0.19)
Return On Assets
(0.57)
Return On Equity
(1.58)
The market value of Can Fite Biopharma is measured differently than its book value, which is the value of Can that is recorded on the company's balance sheet. Investors also form their own opinion of Can Fite's value that differs from its market value or its book value, called intrinsic value, which is Can Fite's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Can Fite's market value can be influenced by many factors that don't directly affect Can Fite's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Can Fite's value and its price as these two are different measures arrived at by different means. Investors typically determine if Can Fite is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Can Fite's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.